|
|
|
|
|
Teisinis statusas
Patentas neįsigaliojo (pagal EPK)
| (51) | INT.CL. | A61K 39/00 | |
| A61K 35/17 | |||
| C12N 5/0783 | |||
| C12N 15/113 |
| (11) | Patento numeris | 3359184 |
| (13) | Dokumento rūšis | T |
| (96) | Europos patento paraiškos numeris | 16782371.5 |
| Europos patento paraiškos padavimo data | 2016-10-05 | |
| (97) | Europos patento paraiškos paskelbimo data | 2018-08-15 |
| (45) | Paskelbimo apie Europos patento išdavimą data | 2020-05-06 |
| (46) | Apibrėžties vertimo paskelbimo data |
| (86) | Numeris | PCT/US2016/055492 |
| Data | 2016-10-05 |
| (87) | Numeris | WO 2017/062451 |
| Data | 2017-04-13 |
| (30) | Numeris | Data | Šalis |
| 201562237394 P | 2015-10-05 | US | |
| 201662297426 P | 2016-02-19 | US |
| (72) |
JANTZ, Derek, US
SMITH, James, Jefferson, US
NICHOLSON, Michael, G., US
MACLEOD, Daniel, T., US
ANTONY, Jeyaraj, US
BARTSEVICH, Victor, US
|
| (73) |
Precision Biosciences, Inc.,
302 East Pettigrew Street Dibrell Building, Suite A-100, Durham, NC 27701,
US
|
| (54) | GENETICALLY-MODIFIED CELLS COMPRISING A MODIFIED HUMAN T CELL RECEPTOR ALPHA CONSTANT REGION GENE |
| GENETICALLY-MODIFIED CELLS COMPRISING A MODIFIED HUMAN T CELL RECEPTOR ALPHA CONSTANT REGION GENE |